BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11696636)

  • 1. In vitro investigations of tumor targeting with (99m)Tc-labeled antisense DNA.
    Zhang YM; Wang Y; Liu N; Zhu ZH; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2001 Nov; 42(11):1660-9. PubMed ID: 11696636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
    Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
    J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense targeting of p-glycoprotein expression in tissue culture.
    Nakamura K; Kubo A; Hnatowich DJ
    J Nucl Med; 2005 Mar; 46(3):509-13. PubMed ID: 15750166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different chelators (HYNIC, MAG3 and DTPA) on tumor cell accumulation and mouse biodistribution of technetium-99m labeled to antisense DNA.
    Zhang YM; Liu N; Zhu ZH; Rusckowski M; Hnatowich DJ
    Eur J Nucl Med; 2000 Nov; 27(11):1700-7. PubMed ID: 11105827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a novel chimera consisting of a chelator-containing Tat peptide conjugated to a morpholino antisense oligomer for technetium-99m labeling and accelerating cellular kinetics.
    Zhang YM; Tung CH; He J; Liu N; Yanachkov I; Liu G; Rusckowski M; Vanderheyden JL
    Nucl Med Biol; 2006 Feb; 33(2):263-9. PubMed ID: 16546682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cationic liposomes enhance cellular/nuclear localization of 99mTc-antisense oligonucleotides in target tumor cells.
    Zhang YM; Rusckowski M; Liu N; Liu C; Hnatowich DJ
    Cancer Biother Radiopharm; 2001 Oct; 16(5):411-9. PubMed ID: 11776758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uptake kinetics of 99mTc-MAG3-antisense oligonucleotide to PCNA and effect on gene expression in vascular smooth muscle cells.
    Zhang YR; Zhang YX; Cao W; Lan XL
    J Nucl Med; 2005 Jun; 46(6):1052-8. PubMed ID: 15937319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence of antisense tumor targeting in mice.
    Nakamura K; Fan C; Liu G; Gupta S; He J; Dou S; Kubo A; Rusckowski M; Hnatowich DJ
    Bioconjug Chem; 2004; 15(6):1475-80. PubMed ID: 15546217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial observations of 99mTc labelled locked nucleic acids for antisense targeting.
    Zhang Y; He J; Liu G; Venderheyden JL; Gupta S; Rusckowski M; Hnatowich DJ
    Nucl Med Commun; 2004 Nov; 25(11):1113-8. PubMed ID: 15577590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preparation and quality control of 99mTc labeled MDR1 oligonucleotide DNAs].
    Fan C; Hnatowich DJ
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Jun; 25(3):712-5. PubMed ID: 18693462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive visualization of RNA delivery with 99mTc-radiolabeled small-interference RNA in tumor xenografts.
    Kang L; Wang RF; Yan P; Liu M; Zhang CL; Yu MM; Cui YG; Xu XJ
    J Nucl Med; 2010 Jun; 51(6):978-86. PubMed ID: 20484428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular imaging of MDM2 messenger RNA with 99mTc-labeled antisense oligonucleotides in experimental human breast cancer xenografts.
    Fu P; Shen B; Zhao C; Tian G
    J Nucl Med; 2010 Nov; 51(11):1805-12. PubMed ID: 20956468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial mechanistic studies of antisense targeting in cells.
    Liu X; Nakamura K; Wang Y; Wang Y; Liu G; He J; Ding H; Lu P; Rusckowski M; Kubo A; Hnatowich DJ
    J Nucl Med; 2006 Feb; 47(2):360-8. PubMed ID: 16455644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor pretargeting in mice using (99m)Tc-labeled morpholino, a DNA analog.
    Liu G; Mang'era K; Liu N; Gupta S; Rusckowski M; Hnatowich DJ
    J Nucl Med; 2002 Mar; 43(3):384-91. PubMed ID: 11884499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell culture and xenograft-bearing animal studies of radiolabeled antisense DNA carrier nanoparticles with streptavidin as a linker.
    Nakamura K; Wang Y; Liu X; Kubo A; Hnatowich DJ
    J Nucl Med; 2007 Nov; 48(11):1845-52. PubMed ID: 17978353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of 99mTc-survivin antisense oligonucleotide in diagnosis of hepatocellular carcinoma: an experiment with mice].
    Gao ZR; Zhang YX; Zhang KJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(33):2327-30. PubMed ID: 16321225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonspecific cellular accumulation of 99mTc-labeled oligonucleotides in culture is influenced by their guanine content.
    Wang Y; Liu X; Zhang Y; Liu G; Rusckowski M; Hnatowich DJ
    Nucl Med Biol; 2007 Jan; 34(1):47-54. PubMed ID: 17210461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and Evaluation of (99m)Tc-Epidermal Growth Factor Receptor (EGFR)-Peptide Nucleic Acid for Visualization of EGFR Messenger RNA Expression in Malignant Tumors.
    Zhao X; Wang N; Ren X; Zhang J; Wang J; Han J; Jia L; Liu Y; Zhang Z
    J Nucl Med; 2014 Jun; 55(6):1008-16. PubMed ID: 24744447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An improved synthesis of NHS-MAG3 for conjugation and radiolabeling of biomolecules with (99m)Tc at room temperature.
    Wang Y; Liu X; Hnatowich DJ
    Nat Protoc; 2007; 2(4):972-8. PubMed ID: 17446896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparison on radiochemical behavior and biological property of antisense oligonucleotide labeled with technetium-99m by two methods: NHS-MAG3 versus SHNHP].
    Li Y; Tan T; Zheng J; Zhang C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):889-93, 902. PubMed ID: 18788302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.